These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11831889)

  • 1. Environmental mimic of receptor interaction: conformational analysis of CCK-15 in solution.
    Albrizio S; Carotenuto A; Fattorusso C; Moroder L; Picone D; Temussi PA; D'Ursi A
    J Med Chem; 2002 Feb; 45(4):762-9. PubMed ID: 11831889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational and molecular modeling studies of sulfated cholecystokinin-15.
    Giragossian C; Stone S; Papini AM; Moroder L; Mierke DF
    Biochem Biophys Res Commun; 2002 May; 293(3):1053-9. PubMed ID: 12051766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of segment 32-47 of cholecystokinin receptor type A in CCK8 binding: synthesis, nuclear magnetic resonance, circular dichroism and fluorescence studies.
    De Luca S; Ragone R; Bracco C; Digilio G; Tesauro D; Saviano M; Pedone C; Morelli G
    J Pept Sci; 2003 Mar; 9(3):156-69. PubMed ID: 12675498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermolecular interactions between cholecystokinin-8 and the third extracellular loop of the cholecystokinin-2 receptor.
    Giragossian C; Mierke DF
    Biochemistry; 2002 Apr; 41(14):4560-6. PubMed ID: 11926817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermolecular interactions between cholecystokinin-8 and the third extracellular loop of the cholecystokinin A receptor.
    Giragossian C; Mierke DF
    Biochemistry; 2001 Apr; 40(13):3804-9. PubMed ID: 11300760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New evidence for a membrane-bound pathway in hormone receptor binding.
    Moroder L; Romano R; Guba W; Mierke DF; Kessler H; Delporte C; Winand J; Christophe J
    Biochemistry; 1993 Dec; 32(49):13551-9. PubMed ID: 7504952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identical primary sequence but different conformations of the bioactive regions of canine CCK-8 and CCK-58.
    Keire DA; Solomon TE; Reeve JR
    Biochem Biophys Res Commun; 1999 Dec; 266(2):400-4. PubMed ID: 10600515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
    Gigoux V; Maigret B; Escrieut C; Silvente-Poirot S; Bouisson M; Fehrentz JA; Moroder L; Gully D; Martinez J; Vaysse N; Fourmy AD
    Protein Sci; 1999 Nov; 8(11):2347-54. PubMed ID: 10595537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of ligand-receptor interactions of cholecystokinin by nuclear magnetic resonance.
    Giragossian C; Mierke DF
    Life Sci; 2003 Jun; 73(6):705-13. PubMed ID: 12801592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermolecular interactions between peptidic and nonpeptidic agonists and the third extracellular loop of the cholecystokinin 1 receptor.
    Giragossian C; Sugg EE; Szewczyk JR; Mierke DF
    J Med Chem; 2003 Jul; 46(16):3476-82. PubMed ID: 12877585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further evidence for a C-terminal structural motif in CCK2 receptor active peptide hormones.
    Stone SR; Giragossian C; Mierke DF; Jackson GE
    Peptides; 2007 Nov; 28(11):2211-22. PubMed ID: 17950490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Step-wise formation of helical structure and side-chain packing in a peptide from scorpion neurotoxin support hierarchic model of protein folding.
    Khandelwal P; Seth S; Hosur RV
    Biophys Chem; 2000 Oct; 87(2-3):139-48. PubMed ID: 11099177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide/benzodiazepine hybrids as ligands of CCK(A) and CCK(B) receptors.
    Escherich A; Lutz J; Escrieut C; Fourmy D; van Neuren AS; Müller G; Schafferhans A; Klebe G; Moroder L
    Biopolymers; 2000-2001; 56(2):55-76. PubMed ID: 11592053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
    Boteju LW; Nikiforovich GV; Haskell-Luevano C; Fang SN; Zalewska T; Stropova D; Yamamura HI; Hruby VJ
    J Med Chem; 1996 Sep; 39(20):4120-4. PubMed ID: 8831778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformationally constrained CCK8 analogues obtained from a rationally designed peptide library as ligands for cholecystokinin type B receptor.
    De Luca S; Saviano M; Della Moglie R; Digilio G; Bracco C; Aloj L; Tarallo L; Pedone C; Morelli G
    ChemMedChem; 2006 Sep; 1(9):997-1006. PubMed ID: 16915602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moleular models for cholecystokinin-A receptor.
    Dawson ES; Henne RM; Miller LJ; Lybrand TP
    Pharmacol Toxicol; 2002 Dec; 91(6):290-6. PubMed ID: 12688371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular complex of cholecystokinin-8 and N-terminus of the cholecystokinin A receptor by NMR spectroscopy.
    Pellegrini M; Mierke DF
    Biochemistry; 1999 Nov; 38(45):14775-83. PubMed ID: 10555959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of peptide 3D structure mimetics: rational design of novel peptoid cholecystokinin receptor antagonists.
    Low CM; Black JW; Broughton HB; Buck IM; Davies JM; Dunstone DJ; Hull RA; Kalindjian SB; McDonald IM; Pether MJ; Shankley NP; Steel KI
    J Med Chem; 2000 Sep; 43(19):3505-17. PubMed ID: 11000005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive influence of two hexafluoro solvents on the structural stabilization of Bombyx mori silk fibroin protein and its derived peptides: 13C NMR and CD studies.
    Ha SW; Asakura T; Kishore R
    Biomacromolecules; 2006 Jan; 7(1):18-23. PubMed ID: 16398492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replacement of glycine with dicarbonyl and related moieties in analogues of the C-terminal pentapeptide of cholecystokinin: CCK(2) agonists displaying a novel binding mode.
    Bellier B; Million ME; DaNascimento S; Meudal H; Kellou S; Maigret B; Garbay C
    J Med Chem; 2000 Oct; 43(20):3614-23. PubMed ID: 11020275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.